✦ LIBER ✦

PCN75 COST-EFFECTIVENESS ANALYSIS OF EGFR MUTATION TESTING IN PATIENTS WITH ADVANCED NON SMALL-CELL LUNG CANCER (ANSCLC) TREATED WITH GEFITINIB OR CARBOPLATIN-PACLITAXEL

✍ Scribed by O Arrieta; P Anaya; RJ López; AC Polanco

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymorphisms of EGFR predict clinical o

✍ Ma, Fei; Sun, Tong; Shi, Yuankai; Yu, Dianke; Tan, Wen; Yang, Ming; Wu, Chen; Ch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 547 KB

The EGFR mutation and its correlation wi

✍ Zhang, X.-T. 📂 Article 📅 2005 🏛 Oxford University Press 🌐 English ⚖ 301 KB

PCN58 A COST UTILITY ANALYSIS OF ERLOTIN

✍ PA Bradbury; R Jang; P Isogai; R Ng; N Mittmann; W Evans; FA Shepherd; NB Leighl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

OP3 Cost-effectiveness of epidermal grow

✍ G. de Lima Lopes; J. Segel; D. Tan; Y. Do; T. Mok; E. Finkelstein 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 34 KB

PD-143 Analysis of EGFr gene mutations i

✍ Freeman, D.; Juan, T.; Sarosi, I.; Crawford, J.; Sandler, A.; Schiller, J.; Prag 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (

✍ G. de Lima Lopes 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB